HIND Vyome Holdings, Inc.

$2.18

Vyome Holdings, Inc. (HIND) is expected to report earnings on November 11, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of -3.5% since its last earnings release on August 12, 2026.

Vyome Reported Earnings
Wednesday, August 12, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.20

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Vyome Holdings, Inc.

Vyome Therapeutics Inc. is a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases principally in the US. Vyome Therapeutics Inc., formerly known as ReShape Lifesciences Inc., is based in CAMBRIDGE, Mass.

Sector

Healthcare

Industry

Drug Manufacturers/Other